Latest news

FPwatch joins the family to monitor contraceptive markets!

Continuing ACTwatch’s tradition of rigorous research, FPwatch is tackling gaps in family planning market research by conducting surveys in five priority FP2020 countries. Funded by the Bill and Melinda Gates Foundation in four countries and the Three Millennium Development Goal Fund in Myanmar, FPwatch is monitoring modern family planning method markets in Ethiopia, Nigeria, the Democratic Republic of Congo (DRC), Myanmar and India.    Read more

Benin

Since 2016, ACTwatch has conducted four outlet surveys, two household surveys, and supply chain research in Benin. ACTwatch data show that the availability of quality-assured artemisinin-based combination therapies in the public sector increased from 63.2% in 2008 to 74.4% in 2011.

 

Cambodia

An ACTwatch interviewer at work in rural Cambodia

Since 2016, ACTwatch has conducted four outlet surveys, two household surveys, and supply chain research in Cambodia. ACTwatch outlet survey results have shown that provider ability to correctly state the recommended first-line treatment for uncomplicated malaria dropped slightly from 96.1% in 2009 to 91.7% in 2011.

Madagascar

Since 2016, ACTwatch has conducted five outlet surveys, two household surveys and supply chain research in Madagascar. ACTwatch findings show that among outlets stocking antimalarials in 2011, 92% of public health facilities and 73% of private, not for-profit health facilities offered rapid diagnostic testing services.  

DR Congo

A rural DRC pharmacy

Since 2016, ACTwatch has conducted three outlet surveys, one household survey, as well as supply chain research in the DRC. ACTwatch findings from 2009 showed that just 1 in 4 drugstores carried the first-line quality-assured ACT compared to 3 in 4 public/not for-profit outlets.

Nigeria

National Primary Health Care Development Agency, Abuja

Since 2016, ACTwatch has conducted four outlet surveys, two household surveys, and supply chain research in Nigeria. ACTwatch findings from 2011 showed that 87% of private, not for-profit facilities offered malaria testing services compared to 26% of public health facilities.

Uganda

View of town from hill

Since 2016, ACTwatch has conducted six outlet surveys, two household surveys, and supply chain research in Uganda. ACTwatch findings indicate that the antimalarial market share of ACTs increased from 22.1% in 2009 to 68.1% in 2011. 

Zambia

Rural site in Zambia

Since 2016, ACTwatch has conducted three outlet surveys, two household surveys, and supply chain research in Zambia. ACTwatch findings showed that in 2008, 83% of public health facilities carried the first-line malaria treatment (artemether lumefantrin), rising to 92.1% in 2011. 

Kenya

A pharmacy in Kitale

PSI conducted two rounds of outlet surveys in 2010 and 2011 in Kenya as part of the Independent Evaluation of the AMFm pilot phase through support from the Global Fund. Kenya joined the roster of ACTwatch countries in 2013. A follow up outlet survey was conducted in early 2014.

Tanzania

A survey underway in Zanzibar

PSI conducted two rounds of outlet surveys in Zanzibar in 2010 and 2011 as part of the Independent Evaluation of the AMFm through support from the Global Fund. Tanzania joined the roster of ACTwatch countries in 2013. The first ACTwatch funded outlet survey was conducted in 2014. A follow up survey will be conducted in 2016.

Myanmar

Myanmar village community health worker

Since 2016, four outlet surveys have been conducted in Myanmar. Although the 2015 outlet survey was the only survey funded by ACTwatch, prior surveys used ACTwatch methodologyMyanmar became a formal member of the ACTwatch country roster in 2013.

 

Our work

ACTwatch is a multi-country research project designed to fill evidence gaps on malaria diagnostics, antimalarial medicines and fever case management in the private and public sectors.

ACTwatch collects data to inform evidence-based malaria control policies and programmes. This is our approach

Access interactive data